Lv3
376 积分 2025-12-17 加入
Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
19天前
已完结
Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients
21天前
已完结
[Diagnosis and treatment of non-alcoholic fatty liver disease. Argentine Association for the Study of Liver Diseases, year 2019]
21天前
已关闭
Non-alcoholic fatty liver disease – 2019
21天前
已完结
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes
28天前
已完结
Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort
28天前
已完结
MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death
28天前
已完结
The steatosis‐associated fibrosis estimator (SAFE) score: A tool to detect low‐risk NAFLD in primary care
28天前
已完结
Liver fibrosis scores predict liver disease mortality in the United States population
28天前
已完结
Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes
28天前
已完结
皖公网安备34019202002308
